WallStreetZenWallStreetZen

NASDAQ: FRLN
Freeline Therapeutics Holdings PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

FRLN earnings and revenue history

Current Revenue
$617.0k
Current Earnings
-$52.7M
Current Profit Margin
-8,547.3%

FRLN Return on Equity

Current Company
-96.3%
Current Industry
1.3%
Current Market
-0.3%
FRLN's Return on Equity (-96.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FRLN announces earnings.

FRLN Return on Assets

Current Company
-63.8%
Current Industry
-1.5%
FRLN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FRLN Return on Capital Employed

Current Company
-118.82%
Current Industry
11.8%
FRLN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FRLN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FRLN$617.00k-$50.77M-$52.74MN/AN/A
TARA$0.00-$66.70M-$67.00MN/AN/A
VBLT$481.00k-$15.52M-$15.96M-49.19%-10.71%
COCP$0.00-$19.22M-$19.56M-100.00%N/A
HEPA$0.00-$45.50M-$45.84MN/AN/A
View Top Biotech Stocks

FRLN earnings dates

Next earnings date
Nov 6, 2023

Freeline Therapeutics Holdings Earnings & Revenue FAQ

What were FRLN's earnings last quarter?

On Invalid Date, Freeline Therapeutics Holdings (NASDAQ: FRLN) reported Q2 2023 earnings per share (EPS) of -$3.75, up 21.88% year over year. Total Freeline Therapeutics Holdings earnings for the quarter were -$16.01 million. In the same quarter last year, Freeline Therapeutics Holdings's earnings per share (EPS) was -$4.80.

If you're new to stock investing, here's how to buy Freeline Therapeutics Holdings stock.

What was FRLN's earnings growth in the past year?

As of Q4 2023, Freeline Therapeutics Holdings's earnings has grown year over year. Freeline Therapeutics Holdings's earnings in the past year totalled -$52.74 million.

What is FRLN's earnings date?

Freeline Therapeutics Holdings's earnings date is Invalid Date. Add FRLN to your watchlist to be reminded of FRLN's next earnings announcement.

What was FRLN's revenue last quarter?

On Invalid Date, Freeline Therapeutics Holdings (NASDAQ: FRLN) reported Q2 2023 revenue of $617.00 thousand up Infinity% year over year. In the same quarter last year, Freeline Therapeutics Holdings's revenue was $0.00.

What was FRLN's revenue growth in the past year?

As of Q4 2023, Freeline Therapeutics Holdings's revenue has grown null year over year. Freeline Therapeutics Holdings's revenue in the past year totalled $617.00 thousand.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.